Clinical study on anti-fungal drug activity against clinically isolated strains of oral Candida species
The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect inform...
        Saved in:
      
    
          | Published in | Oral Science International Vol. 10; no. 2; pp. 87 - 94 | 
|---|---|
| Main Authors | , , , , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
            Elsevier Ltd
    
        01.05.2013
     Wiley  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1348-8643 1881-4204  | 
| DOI | 10.1016/S1348-8643(13)00006-2 | 
Cover
| Abstract | The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC.
The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined.
Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH-B and 5-FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH-B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms.
MIC values of anti-fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti-fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value). | 
    
|---|---|
| AbstractList | The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC.
The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined.
Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH-B and 5-FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH-B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms.
MIC values of anti-fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti-fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value). Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC. Subjects and methods: The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined. Results: Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C. glabrata (19 strains), and C. tropicalis (4 strains). AMPH‐B and 5‐FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida, FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH‐B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms. Conclusion: MIC values of anti‐fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti‐fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value). Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ), miconazole (MCZ), itraconazole (ITCZ), and micafungin (MCFG) against clinically isolated Candida strains from oral candidiasis (OC) patients and to collect information useful for the treatment of OC. Subjects and methods: The study includes 116 strains of Candida isolated from patients. The Candida species were identified by polymerase chain reaction. The minimum inhibitory concentration (MIC) of each drug against each Candida species was determined. Results: Of the 106 participants (30 males and 76 females), 57 had OC, including 42 cases of pseudomembranous OC, 11 cases of erythematous OC, 2 cases of hypertrophic OC, and 2 cases of mixed pseudomembranous/erythematous OC. The Candida species isolated were Candida albicans (93 strains), C . glabrata (19 strains), and C. tropicalis (4 strains). AMPH‐B and 5‐FC had low MIC values against all species of Candida and a low incidence of resistance development. In some species of Candida , FLCZ and ITCZ showed high MICs, but MCZ had a low MIC value. AMPH‐B, MCZ, and ITCZ prescribed to OC patients were effective against OC with respect to alleviation of OC symptoms. Conclusion: MIC values of anti‐fungal drugs against Candida strains isolated from OC patients were obtained and the 3 anti‐fungal drugs given to OC patients were found to be effective against OC in spite of differences in their MIC values and in the number of resistant strains (or strains with a high MIC value).  | 
    
| Author | Hirabayashi, Daisuke Kawasaki, Kiyotsugu Sato, Tomoaki Nagayama, Tomohiro Sugihara, Kazumasa Mori, Youichiro Kamikawa, Yasuko Mukai, Hiroshi Fujisaki, Junichi Hamada, Tomofumi Kamikawa, Yoshiaki  | 
    
| Author_xml | – sequence: 1 givenname: Yoshiaki surname: Kamikawa fullname: Kamikawa, Yoshiaki email: zenkamikawa@mac.com, kamikawa@dent.kagoshima-u.ac.jp organization: Department of Oral Surgery, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan – sequence: 2 givenname: Tomohiro surname: Nagayama fullname: Nagayama, Tomohiro organization: Department of Applied Pharmacology, Field of Functional Biology and Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 3 givenname: Junichi surname: Fujisaki fullname: Fujisaki, Junichi organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 4 givenname: Daisuke surname: Hirabayashi fullname: Hirabayashi, Daisuke organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 5 givenname: Kiyotsugu surname: Kawasaki fullname: Kawasaki, Kiyotsugu organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 6 givenname: Tomofumi surname: Hamada fullname: Hamada, Tomofumi organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 7 givenname: Youichiro surname: Mori fullname: Mori, Youichiro organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 8 givenname: Yasuko surname: Kamikawa fullname: Kamikawa, Yasuko organization: Department of Maxillofacial Diagnostic and Surgical Science, Field of Oral and Maxillofacial Rehabilitation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 9 givenname: Hiroshi surname: Mukai fullname: Mukai, Hiroshi organization: Department of Oral Surgery, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan – sequence: 10 givenname: Tomoaki surname: Sato fullname: Sato, Tomoaki organization: Department of Applied Pharmacology, Field of Functional Biology and Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 11 givenname: Kazumasa surname: Sugihara fullname: Sugihara, Kazumasa organization: Department of Oral Surgery, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan  | 
    
| BackLink | https://cir.nii.ac.jp/crid/1872835442410445184$$DView record in CiNii | 
    
| BookMark | eNqNkE1rHSEUhqUk0CTtTyi46CJdTOpRx3EIpZRLviCQRdK1eNW5nDJ1gnpT5t_HuTfZZJO60IO-j0efY3IQpxgI-QLsDBio7_cgpG60kuIUxDdWh2r4B3IEWkMjOZMHtX6NfCTHOf9hrFW9UEdksxoxorMjzWXrZzpFamPBZtjGTd30abuh1hV8wjJTu7EYc6HuhRlninkabQm-4mk5pNNAp1TJlY0evaX5MTgM-RM5HOyYw-eX9YT8vrx4WF03t3dXN6tft42TmvPGgRWyg06t170UAQT3odO25V1grVR-3WrHlLaq56rrOOvBStt7zjsY1o4zcULa_b0uTTmnMJjHhH9tmg0ws9gyO1tmUWFAmJ0twyt3_oZzWGzBKS7_Gt-lf-zpfziG-f9amrv7G76rF_7rno-ItfEyg-64Fq2UXAKTsgUta-znPhaqwScMyeTqNrrgMQVXjJ_wnYc-Az3Codg | 
    
| CitedBy_id | crossref_primary_10_1007_s10096_014_2240_6 crossref_primary_10_1186_1472_6831_14_14  | 
    
| Cites_doi | 10.1128/JCM.02434-08 10.1111/j.1399-302X.2005.00236.x 10.1093/jac/dkh053 10.1128/JCM.36.7.1886-1889.1998 10.1186/1471-2180-8-135 10.1086/423377 10.1002/yea.892 10.1086/596757 10.1086/323401 10.1254/fpj.130.69 10.1016/S0732-8893(02)00440-6 10.1016/S0002-9343(02)01191-9 10.1086/423378  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2013 Japanese Stomatological Society | 
    
| Copyright_xml | – notice: 2013 Japanese Stomatological Society | 
    
| DBID | 6I. AAFTH RYH AAYXX CITATION  | 
    
| DOI | 10.1016/S1348-8643(13)00006-2 | 
    
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CiNii Complete CrossRef  | 
    
| DatabaseTitle | CrossRef | 
    
| DatabaseTitleList | CrossRef  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Dentistry | 
    
| EISSN | 1881-4204 | 
    
| EndPage | 94 | 
    
| ExternalDocumentID | 10_1016_S1348_8643_13_00006_2 OSI2000062 S1348864313000062  | 
    
| Genre | article | 
    
| GroupedDBID | --K --M .55 .~1 0R~ 1OC 1~. 2WC 33P 34H 4.4 457 4G. 6I. 7-5 8P~ AACTN AAEDT AAEDW AAFTH AAHHS AAIKJ AALRI AANLZ AAOAW AAXUO ABBQC ABCUV ABGSF ABJNI ABMAC ABMZM ABQWH ABVKL ABXDB ABYKQ ACCFJ ACCZN ACGFS ACGOF ACPOU ACXQS ADBBV ADBTR ADEZE ADKYN ADMUD ADUVX ADXAS ADZMN AEEZP AEIGN AEKER AEQDE AEUYR AEXQZ AFFPM AGHFR AGUBO AGYEJ AHBTC AITUG AIURR AIWBW AJBDE AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS ALUQN AMFUW AMRAJ AMYDB ANZVX BFHJK BLXMC C45 DCZOG DOVZS EBS EFLBG EJD FDB FEDTE FIRID FNPLU GBLVA HVGLF HZ~ JSF JSH KQ8 LATKE LCYCR LEEKS LYRES M41 MO0 NCXOZ O-L O9- OAUVE OK1 OVD P-8 P-9 P2W PC. Q38 RJT ROL RZJ SDF SES SSZ SUPJJ T5K TEORI TKC TR2 WXSBR X7M ZZTAW AAHQN AAIPD AAMNL AAYCA AAYWO ACVFH ADCNI ADVLN AEUPX AEYWJ AFPUW AFWVQ AGYGG AIGII AITYG AKBMS AKRWK AKYEP ALVPJ HGLYW RYH 0SF ABWVN ACRPL ADNMO AAMMB AAYXX AEFGJ AGHNM AGXDD AIDQK AIDYY CITATION LH4 ~HD  | 
    
| ID | FETCH-LOGICAL-c4822-c1a347176bb943e132de78a527e0546db58c068a6926772091a4a9d2271fbc203 | 
    
| IEDL.DBID | .~1 | 
    
| ISSN | 1348-8643 | 
    
| IngestDate | Wed Oct 01 03:28:14 EDT 2025 Thu Apr 24 22:58:57 EDT 2025 Wed Jan 22 16:21:33 EST 2025 Thu Jun 26 21:08:56 EDT 2025 Fri Feb 23 02:29:36 EST 2024  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 2 | 
    
| Keywords | Minimal inhibitory concentration Oral Candida species Anti-fungal drug activity Clinically isolated strains  | 
    
| Language | English | 
    
| License | http://www.elsevier.com/open-access/userlicense/1.0 | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c4822-c1a347176bb943e132de78a527e0546db58c068a6926772091a4a9d2271fbc203 | 
    
| ORCID | 0000-0001-9147-396X | 
    
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1348864313000062 | 
    
| PageCount | 8 | 
    
| ParticipantIDs | crossref_primary_10_1016_S1348_8643_13_00006_2 crossref_citationtrail_10_1016_S1348_8643_13_00006_2 wiley_primary_10_1016_S1348_8643_13_00006_2_OSI2000062 nii_cinii_1872835442410445184 elsevier_sciencedirect_doi_10_1016_S1348_8643_13_00006_2  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | May 2013 | 
    
| PublicationDateYYYYMMDD | 2013-05-01 | 
    
| PublicationDate_xml | – month: 05 year: 2013 text: May 2013  | 
    
| PublicationDecade | 2010 | 
    
| PublicationTitle | Oral Science International | 
    
| PublicationYear | 2013 | 
    
| Publisher | Elsevier Ltd Wiley  | 
    
| Publisher_xml | – name: Elsevier Ltd – name: Wiley  | 
    
| References | Pfaller, Jones, Doern (bib0005) 1998; 36 (bib0110) 2011 Yamaguchi, Enomoto, Kaku (bib0100) 2006; 54 Yamaguchi, Uchida, Nishiyama (bib0045) 2006; 16 Kanbe, Horii, Arishima (bib0055) 2002; 19 Villanueva, Arathoon, Gotuzzo (bib0015) 2001; 33 Clinical and Laboratory Standards Institute (bib0065) 2008 Messer, Moet, Kirby (bib0010) 2009; 47 Villanueva, Gotuzzo, Arathoon (bib0020) 2002; 113 Yamaguchi, Uchida, Okuzumi (bib0040) 2004; 14 Hamza, Matee, Moshi (bib0090) 2008; 8 Yamaguchi, Nishiyama, Uchida (bib0050) 2009; 19 Pappas, Kauffman, Andes (bib0060) 2009; 48 de Wet, Llanos-Cuentas, Suleiman (bib0025) 2004; 39 Yamaguchi (bib0070) 2009; 55 Takakura, Fujihara, Saito (bib0035) 2004; 53 Sudo, Makimura, Kawata (bib0075) 1997; 45 Blignaut, Messer, Hollis (bib0080) 2002; 44 Kuriyama, Williams, Bagg (bib0085) 2005; 20 Krause, Simjee, van Rensburg (bib0030) 2004; 39 Otani, Unoue, Shiota (bib0105) 2007; 130 Yamaguchi (bib0095) 2010; 56 Yamaguchi H (e_1_2_7_1_10_2) 2006; 16 e_1_2_7_1_22_2 e_1_2_7_1_12_2 e_1_2_7_1_8_2 Yamaguchi H (e_1_2_7_1_21_2) 2006; 54 Yamaguchi H (e_1_2_7_1_11_2) 2009; 19 (e_1_2_7_1_23_2) 2011 Sudo T (e_1_2_7_1_16_2) 1997; 45 Yamaguchi H. (e_1_2_7_1_15_2) 2009; 55 e_1_2_7_1_4_2 Clinical and Laboratory Standards Institute (e_1_2_7_1_14_2) 2008 e_1_2_7_1_17_2 e_1_2_7_1_5_2 e_1_2_7_1_18_2 e_1_2_7_1_6_2 e_1_2_7_1_19_2 e_1_2_7_1_7_2 e_1_2_7_1_13_2 e_1_2_7_1_2_2 Yamaguchi H. (e_1_2_7_1_20_2) 2010; 56 e_1_2_7_1_3_2 Yamaguchi H (e_1_2_7_1_9_2) 2004; 14  | 
    
| References_xml | – start-page: 16 year: 2011 ident: bib0110 article-title: Interview Form FLORID Oral gel 2% – volume: 20 start-page: 349 year: 2005 end-page: 353 ident: bib0085 article-title: In vitro susceptibility of oral publication-title: Oral Microbiol Immunol – volume: 47 start-page: 1942 year: 2009 end-page: 1946 ident: bib0010 article-title: Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against publication-title: J Clin Microbiol – volume: 45 start-page: 115 year: 1997 end-page: 122 ident: bib0075 article-title: Evaluation of antifungal susceptibility testing by the broth micro dilution method against publication-title: Jpn J Chemother – volume: 113 start-page: 294 year: 2002 end-page: 299 ident: bib0020 article-title: A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis publication-title: Am J Med – volume: 8 start-page: 135 year: 2008 ident: bib0090 article-title: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis publication-title: BMC Microbiol – volume: 33 start-page: 1529 year: 2001 end-page: 1535 ident: bib0015 article-title: A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis publication-title: Clin Infect Dis – volume: 36 start-page: 1886 year: 1998 end-page: 1889 ident: bib0005 article-title: International surveillance of blood stream infections due to publication-title: J Clin Microbiol – volume: 39 start-page: 842 year: 2004 end-page: 849 ident: bib0025 article-title: A randomized, double blind, parallel group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV positive patients publication-title: Clin Infect Dis – volume: 14 start-page: 183 year: 2004 end-page: 193 ident: bib0040 article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2001–2002 publication-title: J Jpn Soc Clin Microbiol – volume: 16 start-page: 13 year: 2006 end-page: 22 ident: bib0045 article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2003 publication-title: J Jpn Soc Clin Microbiol – volume: 48 start-page: 503 year: 2009 end-page: 535 ident: bib0060 article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America publication-title: Clin Infect Dis – year: 2008 ident: bib0065 article-title: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-third edition M27-A3 – volume: 56 start-page: 119 year: 2010 end-page: 138 ident: bib0095 article-title: Epidemiology of antifungal resistance: current status and future perspective publication-title: Modern Media – volume: 53 start-page: 283 year: 2004 end-page: 289 ident: bib0035 article-title: National surveillance of species distribution in blood isolates of publication-title: J Antimicrob Chemother – volume: 54 start-page: 18 year: 2006 end-page: 31 ident: bib0100 article-title: An open randomized parallel-comparison study of itraconazole oral solution versus itraconazole capsules in treatment of patients with oropharyngeal candidiasis publication-title: Jpn J Chemother – volume: 19 start-page: 128 year: 2009 end-page: 141 ident: bib0050 article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2005 publication-title: J Jpn Soc Clin Microbiol – volume: 19 start-page: 973 year: 2002 end-page: 989 ident: bib0055 article-title: PCR-based identification of pathogenic publication-title: Yeast – volume: 130 start-page: 69 year: 2007 end-page: 76 ident: bib0105 article-title: Pharmacological, pharmacokinetic, and clinical profile of itraconazole ore solution (ITRIZOLE Oral Solution 1%) publication-title: Folia Pharmacol Jpn – volume: 39 start-page: 770 year: 2004 end-page: 775 ident: bib0030 article-title: A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis publication-title: Clin Infect Dis – volume: 44 start-page: 169 year: 2002 end-page: 174 ident: bib0080 article-title: Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals publication-title: Diagn Microbiol Infect Dis – volume: 55 start-page: 309 year: 2009 end-page: 320 ident: bib0070 article-title: Anti fungal drug sensitivity test publication-title: Modern Media – ident: e_1_2_7_1_3_2 doi: 10.1128/JCM.02434-08 – ident: e_1_2_7_1_18_2 doi: 10.1111/j.1399-302X.2005.00236.x – ident: e_1_2_7_1_8_2 doi: 10.1093/jac/dkh053 – volume: 19 start-page: 128 year: 2009 ident: e_1_2_7_1_11_2 article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Anti‐fungal Surveillance Program (JASP), 2005 publication-title: J Jpn Soc Clin Microbiol – ident: e_1_2_7_1_2_2 doi: 10.1128/JCM.36.7.1886-1889.1998 – ident: e_1_2_7_1_19_2 doi: 10.1186/1471-2180-8-135 – ident: e_1_2_7_1_6_2 doi: 10.1086/423377 – ident: e_1_2_7_1_12_2 doi: 10.1002/yea.892 – volume: 55 start-page: 309 year: 2009 ident: e_1_2_7_1_15_2 article-title: Anti fungal drug sensitivity test publication-title: Modern Media – volume-title: Interview Form FLORID Oral gel 2%. year: 2011 ident: e_1_2_7_1_23_2 – volume: 45 start-page: 115 year: 1997 ident: e_1_2_7_1_16_2 article-title: Evaluation of antifungal susceptibility testing by the broth micro dilution method against Candida species: activities of 5 antifungal agents against Candida species isolated from oral candidiasis or other candidal infectious diseases and correlation of vitro data and clinical outcome of fluconazole therapy publication-title: Jpn J Chemother – volume: 14 start-page: 183 year: 2004 ident: e_1_2_7_1_9_2 article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2001–2002 publication-title: J Jpn Soc Clin Microbiol – ident: e_1_2_7_1_13_2 doi: 10.1086/596757 – ident: e_1_2_7_1_4_2 doi: 10.1086/323401 – ident: e_1_2_7_1_22_2 doi: 10.1254/fpj.130.69 – ident: e_1_2_7_1_17_2 doi: 10.1016/S0732-8893(02)00440-6 – start-page: M27 volume-title: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard year: 2008 ident: e_1_2_7_1_14_2 – volume: 54 start-page: 18 issue: 1 year: 2006 ident: e_1_2_7_1_21_2 article-title: An open randomized parallel‐comparison study of itraconazole oral solution versus itraconazole capsules in treatment of patients with oropharyngeal candidiasis publication-title: Jpn J Chemother – volume: 16 start-page: 13 year: 2006 ident: e_1_2_7_1_10_2 article-title: Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Anti‐fungal Surveillance Program (JASP), 2003 publication-title: J Jpn Soc Clin Microbiol – ident: e_1_2_7_1_5_2 doi: 10.1016/S0002-9343(02)01191-9 – ident: e_1_2_7_1_7_2 doi: 10.1086/423378 – volume: 56 start-page: 119 year: 2010 ident: e_1_2_7_1_20_2 article-title: Epidemiology of antifungal resistance: current status and future perspective publication-title: Modern Media  | 
    
| SSID | ssj0056936 ssib058494013 ssib050995472  | 
    
| Score | 1.8605108 | 
    
| Snippet | The present study was undertaken to evaluate the anti-fungal activity of amphotericin B (AMPH-B), flucytosine (5-FC), fluconazole (FLCZ), miconazole (MCZ),... Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ),... Objectives: The present study was undertaken to evaluate the anti‐fungal activity of amphotericin B (AMPH‐B), flucytosine (5‐FC), fluconazole (FLCZ),...  | 
    
| SourceID | crossref wiley nii elsevier  | 
    
| SourceType | Enrichment Source Index Database Publisher  | 
    
| StartPage | 87 | 
    
| SubjectTerms | Anti-fungal drug activity Clinically isolated strains Minimal inhibitory concentration Oral Candida species  | 
    
| Title | Clinical study on anti-fungal drug activity against clinically isolated strains of oral Candida species | 
    
| URI | https://dx.doi.org/10.1016/S1348-8643(13)00006-2 https://cir.nii.ac.jp/crid/1872835442410445184 https://onlinelibrary.wiley.com/doi/abs/10.1016%2FS1348-8643%2813%2900006-2  | 
    
| Volume | 10 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1881-4204 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056936 issn: 1348-8643 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1881-4204 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056936 issn: 1348-8643 databaseCode: .~1 dateStart: 20040501 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1881-4204 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0056936 issn: 1348-8643 databaseCode: AKRWK dateStart: 20040501 isFulltext: true providerName: Library Specific Holdings  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09SzQxEA6-Ntq8-InnFykstIi3yWY32VJORQW18BXsQrJJjoVjT_wobPztzmT3TixeFJstQhKGyZB5ws4zDyEHobZcucwyz-GlIy13TMfIWeA8jxWP0UYkJ1_flBf38uqheFggoxkXBssq-7u_u9PTbd2PDHtvDh-bZnjHcwg-SKj4QwapgMhglwpVDI7f52UeRVklmUCczHD2J4un2yENHvL8KG3CxP_y05-2ab4C2JSBzlfI3x460pPOulWyENo1snSK5T6o2LZOxn2TzwlNTWPptKXgt4ZB7oI8QP3T65gijwHlIqgd2wagIZ1RIydvtIE4BOjp6XMSjnim00iRwE9HyH3xliItE17WG-T-_Ozf6IL1QgqslgAAWM1tDklIlc5VMg_wAPVBaVsIFQCxld4Vus5KbctKlIC2AUJYaSsvhOLR1SLLN8liO23DFqEBG9BpX4c6c1LFXBfWRVX56GLmgrcDImfuM3XfZRxtnph5ORl63aDXDc9N8roRA3I8X_bYtdn4boGenY35Ei8GUsF3S_fgLME6_HKtsOOclIBkMmzWpuWAlOmUf2aIub27FF0Abv_eph2yLJLOBlZS7pLFl6fXsAdo58Xtp3D-AClx8Xg | 
    
| linkProvider | Elsevier | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9wwDCbyGNIl6CNFL20aDR2aQTlLlm15LK4NLs2jQxIgmyBZ0sHAwRfkMWTpby8p-67IUKTI4kGQBIIkxI8wPxLgS2isqFxmuReY6SgrHNcxCh6EyGMtYrSRyMln5-X0Sv28Lq7XYLLkwlBZ5fD29296eq2HlfGgzfFN244vRI7OhwGVfsgQFXAdNlUhK8rADn-v6jyKsk5zAmk3p-1_aTz9FWnxq8gP0i1c_itArXdt-xTBphB09Bq2B-zIvvXivYG10L2Fre9U70Mj297BbOjyOWepayxbdAwV13IMXhgImL99mDEiMtC8CGZntkVsyJbcyPkja9EREXt6dpcmR9yxRWTE4GcTIr94y4iXian1Dlwd_bicTPkwSYE3ChEAb4TNMQpVpXO1ygNmoD5U2qK2AkK20rtCN1mpbVnLEuE2YgirbO2lrER0jczy97DRLbrwAVigDnTaN6HJnKpirgvrYlX76GLmgrcjUEv1mWZoM04yz82qnoy0bkjrRuQmad3IERyujt30fTaeO6CXtjFPHMZgLHju6B7aEqWjr9AVtZxTCqFMRt3atBpBmaz8f4KYXxfHsvfA3ZfLtA9b08uzU3N6fH7yEV7JNHSDyio_wcb97UPYQ-hz7z4n1_4DZdz0mw | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+study+on+anti%E2%80%90fungal+drug+activity+against+clinically+isolated+strains+of+oral+Candida+species&rft.jtitle=Oral+science+international&rft.au=Kamikawa%2C+Yoshiaki&rft.au=Nagayama%2C+Tomohiro&rft.au=Fujisaki%2C+Junichi&rft.au=Hirabayashi%2C+Daisuke&rft.date=2013-05-01&rft.issn=1348-8643&rft.eissn=1881-4204&rft.volume=10&rft.issue=2&rft.spage=87&rft.epage=94&rft_id=info:doi/10.1016%2FS1348-8643%2813%2900006-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S1348_8643_13_00006_2 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1348-8643&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1348-8643&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1348-8643&client=summon |